Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMeridian is a medical technology company specializing in the development of meridian stress assessment (MSA) systems and electrodermal screening devices. The company's technology measures electrical conductivity at specific acupuncture points on the body to assess the functional status of various physiological systems. Its flagship products, such as the MSAS-Professional and Vantage systems, are designed for use by integrative healthcare practitioners to identify sensitivities and nutritional imbalances. BioMeridian's software platforms provide comprehensive reporting to assist in the creation of personalized wellness protocols. The company was a significant player in the bio-energetic testing market before its acquisition by International Health Technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMeridian.